Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients - Concepedia

Concepedia

Publication | Closed Access

Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients

88

Citations

25

References

2006

Year

Anieta M. Sieuwerts, Maxime P. Look, Marion E. Meijer‐van Gelder, Mieke Timmermans, Anita M.A.C. Trapman, Roberto Rodríguez García, Miranda Arnold, Anneke J.W. Goedheer, Vanja de Weerd, Henk Portengen,

Clinical Cancer Research

Abstract

Our study shows that both CCNE1 and CCNE2 qualify as independent prognostic markers for lymph node-negative breast cancer patients, and that CCNE1 may provide additional information for specific subgroups of patients.

References

	Year	Citations

Page 1